The role of surgery for patients with metastatic melanoma

Current Opinion in Oncology

Volumn 14, Issue 2, 2002, Pages 221-226

  Allen, Peter J ^a   Coit, Daniel G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN METASTASIS; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LUNG METASTASIS; MELANOMA; METASTASIS; MORBIDITY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

ADRENAL GLAND NEOPLASMS; BRAIN NEOPLASMS; CLINICAL TRIALS; GASTROINTESTINAL NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; PROGNOSIS; SKIN NEOPLASMS;

EID: 0036128419     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200203000-00014     Document Type: Review

References (51)

1. Prognosis for recurrent stage I malignant melanoma
2. Prognosis after initial recurrence of cutaneous melanoma
3. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis
4. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic
5. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III)
6. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma
7. Survival with regional and distant metastases from cutaneous malignant melanoma
8. Prognostic factors in 1,521 melanoma patients with distant metastases
9. Lung metastases from melanoma: When is surgical treatment warranted?
10. A new American Joint Committee on Cancer staging system for cutaneous melanoma
11. Prognostic factors for survival of patients treated systemically for disseminated melanoma
12. Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors
13. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma
14. Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma
15. Surgical palliation at a cancer center: Incidence and outcomes
16. Surgery as palliative treatment for distant metastases of melanoma
17. Prognostic parameters in recurrent malignant melanoma
18. Analysis of 945 cases of pulmonary metastatic melanoma
19. Surgical resection for metastatic melanoma to the liver: The John Wayne Cancer Institute and Sydney Melanoma Unit experience
20. Radiologic imaging in malignant melanoma: A review
21. Melanoma metastatic to the spine: A review of 133 cases
22. The use of bone and brain scans as screening procedures in patients with malignant lesions
23. Radionuclide scanning in patients with advanced malignant melanoma
24. The role of bone scans in assessing malignant melanoma in patients with stage III disease
25. The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma
26. The natural history of resectable metastatic melanoma (Stage IVA melanoma)
27. Improved survival after resection of pulmonary metastases from malignant melanoma
28. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax
29. Radiologic, endoscopic, and surgical considerations of melanoma metastatic to the gastrointestinal tract
30. Metastatic melanoma of the gastrointestinal tract
31. Surgical resection for melanoma metastatic to the gastrointestinal tract
32. Secondary tumors of the gastrointestinal tract: Surgical pathologic findings and comparison with autopsy survey
33. Gastrointestinal metastases from malignant melanoma
34. Cerebral metastases from malignant melanoma
35. Stereotactic radiosurgery for cerebral metastatic melanoma
36. Gamma knife radiosurgery for metastatic melanoma: An analysis of survival, outcome, and complications
37. Stereotactic radiosurgery for cerebral metastatic melanoma: Factors affecting local disease control and survival
38. Gamma knife radiosurgery for malignant melanoma brain metastases
39. Surgical treatment of brain metastases in malignant melanoma
40. Solitary cerebral metastasis from melanoma: Value of the 'en bloc' resection
41. Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients
42. Long-term survival after complete resection of melanoma metastatic to the adrenal gland
43. The role of resection in the management of melanoma metastatic to the adrenal gland
44. The role of surgery in the treatment of clinically isolated adrenal metastasis
45. Surgery for melanoma metastatic to the gastrointestinal tract
46. Basic principles in surgical oncology
47. Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma
48. Selection factors resulting in improved survival after surgical resection of tumors metastatic to the lungs
49. Thoracotomy for metastatic malignant melanoma of the lung
50. The role of radiation therapy following resection of single brain metastasis from melanoma
51. Palliative surgery for brain metastases of malignant melanoma